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A novel HIV-1 transgenic rat model of childhood HIV-1– proteinuria, and developed rapid progression to end-stage
associated nephropathy. renal disease (ESRD) [1, 2]. Renal biopsy and autopsy
Background. A characteristic finding of human immunode- studies showed the presence of large edematous kidneys,ficiency virus (HIV)-associated nephropathy (HIVAN) is the
which contrasted with the small fibrotic kidneys typicallypresence of heavy proteinuria, focal or global glomerulosclero-
seen in patients with chronic renal diseases of other eti-sis, and microcystic tubular dilatation leading to renal enlarge-
ment, and rapid progression to end-stage renal disease (ESRD). ology. In addition HIV-infected patients showed ex-
Methods. We have recently developed the first HIV-1 trans- tensive glomerular capillary collapse and pronounced
genic rat model that carry a noninfectious HIV-1 DNA con-
hypertrophy and hyperplasia of visceral epithelial cellsstruct lacking 3.1 kb of sequence overlapping the gag and pol
associated with focal segmental and global sclerosissequences, and develop many of the clinical lesions seen in
HIV-infected patients, including HIVAN. To gain further in- [1–3]. There was also severe tubulointerstitial injury and
sight into the pathogenesis of childhood HIVAN, we followed dilated tubules containing large casts, as well as frequent
the clinical and renal pathologic outcome of 165 HIV-1 trans- tubuloreticular inclusions in glomerular endothelial cells.genic (HIV-Tg) rats and their respective control littermates for
This renal syndrome, termed HIV-associated nephropa-a period of 18 months.
thy (HIVAN), was found predominately in HIV-infectedResults. HIV-1 Tg rats progressively developed proteinuria
and renal histologic lesions similar to those seen in children African Americans [4, 5]. The presence of familial clus-
with HIVAN, leading to chronic renal failure. By in situ hybrid- tering of ESRD in African Americans with HIVAN sug-
ization, HIV-1 genes were detected in glomerular and tubular
gests that these patients may have an inherited suscepti-epithelial cells and infiltrating mononuclear cells, which also
bility to develop ESRD [6] when exposed to HIV-1.expressed the HIV-1 envelop protein gp120. The development
of HIVAN was associated with the accumulation of basic fi- Almost immediately after the first cases of HIVAN
broblast growth factor (bFGF) in the kidney. were reported, a controversy developed over the issue
Conclusion. These data support the notion that HIV-1 plays of whether the use of injected illegal drugs, or HIV-1a direct role in the pathogenesis of HIVAN, by affecting the
per se, were directly involved in the pathogenesis of thisfunction and growth of renal epithelial cells, inducing the re-
disease [7, 8]. Subsequent studies demonstrated HIVANcruitment of mononuclear cells, and accumulating bFGF in the
kidney, even in the absence of viral replication. These rats may in children who acquired HIV-1 through vertical trans-
provide an excellent model system to study the pathogenesis mission [9–11], suggesting that HIV-1 infection per se
of childhood HIVAN.
was involved in the pathogenesis of HIVAN. In addition,
HIV-1 transgenic (HIV-Tg) mice carrying a replication
defective HIV-1 provirus were generated, and these ani-
In 1984, human immunodeficiency virus (HIV)-infected mals developed a similar renal disease, even in the absence
patients from New York and Miami presented with heavy
of immunosuppression and viral replication [12, 13].
Taken together, these findings support the notion that
HIV-1 is directly involved in the pathogenesis of HI-Key words: childhood HIV-1 nephropathy, HIV-transgenic rats, basic
FGF, captopril. VAN. More recently, this notion has been strengthen
by studies demonstrating an improvement in the clinical
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genes/viral products throughout their gestation and post- Definitions
natal periods, we are using HIV-Tg rodents to study HIV-Tg rats showing normal renal histology under
the pathogenesis of childhood HIVAN. In the HIV-Tg light microscopy, and without abnormal proteinuria (30
mouse line, Tg26, we provided the first evidence that the mg/dL) were considered without renal disease. An early
expression of HIV-1 genes in tubular epithelial cells was clinical diagnosis of HIVAN was suspected by the pres-
associated with the development of renal enlargement ence of persistent and progressive proteinuria (100
and microcystic lesions characteristic of HIVAN [17]. In mg/dL). In this study, these rats are referred to as
a follow-up study, we demonstrated that HIV-1 can in- HIV-Tg rats with proteinuria, unless indicated otherwise.
fect primary human renal tubular epithelial cells derived The diagnosis of HIVAN was confirmed by renal histol-
from children with HIVAN [18]. Other studies have ogy. Late HIVAN was defined clinically by the presence
shown that HIV-1 can infect cultured adult human renal of persistent heavy proteinuria (2000 mg/day) and/or
epithelial cells [19], detected HIV-1 RNA in glomerular elevated blood urea nitrogen (BUN) and creatinine val-
and tubular epithelial cells in renal sections from adult ues and confirmed by the presence of severe focal/global
patients with HIVAN [7, 20], and showed in vivo evi- glomerulosclerosis, and generalized tubular dilatation
dence of HIV-1 replication in renal epithelial cells [21]. with casts and microcysts. All these criteria were defined
Here, we describe for the first time the clinical and histo- prior to the initiation of the study.
logic outcome of HIVAN in HIV-Tg rats carrying a
replication-defective HIV-1 provirus similar to the one Biochemical analysis
introduced into HIV-Tg26 mice, and discuss the clinical Blood was collected to measure the hematocrit as de-
relevance of this new model in the context of the patho- scribed before [23]. Serum samples were collected in ice-
genesis of childhood HIVAN. cold tubes to measure BUN, creatinine, albumin, choles-
terol, and triglycerides, using commercially available kits
at the Animal Diagnostic Laboratory LLC (Baltimore,METHODS
MD, USA). Hematuria and proteinuria were measuredHIV-Tg rats
with commercially available test strips. Urine protein/
Animal care was in accordance with the National Insti-
creatinine ratios were measured with a colorimetric assay
tutes of Health Guide for the Care and Use of Labora-
and the picric acid method for protein and creatinine
tory Animals. The generation of the HIV-Tg rat model,
values, respectively. Urinalysis and cast were observedand the overall description of the HIV-Tg (line 1), were
by light microscopy in samples of unspun urine.described in detail in a previous publication [22]. Briefly,
HIV-Tg rats were generated using a construct derived Blood pressure measurements
from the infectious HIV-1 provirus, pNL4-3, after dele-
Systolic arterial blood pressure measurements weretion of a 3.1 kb Sph1-Bal1 fragment that overlaps the
taken in conscious restrained rats using an automatedgag and pol genes (pNL4-3:d1443) [22]. Detection of the
system with a photoelectric tail-cuff [23]. After the ratsHIV-transgene was done by Southern blot analysis of
were preconditioned to the chamber, the mean of threetail DNA as previously described [22]. The HIV-Tg rats
blood pressure readings was collected. The blood pres-were derived from the Fisher 344/NHsd Sprague-Dawley
sure was also measured in HIV-Tg rats with proteinuriabackground. Nontransgenic Fisher 344/NHsd Sprague-
(30 mg/dL) but without renal failure (BUN16 mg/dL),Dawley littermates were used as controls.
treated with 40 mg/L captopril (Bristol-Myers Squibb,
Princeton, NJ, USA), or vehicle [phosphate-buffered sa-Experimental design
line (PBS)] in the drinking water (N  4 in each group).A total of 165 HIV-Tg rats (line 1), and their nontrans-
genic siblings were followed longitudinally from birth up
Morphologic analysisto 18 months of age. Renal histology was done in 99
Light microscopy. Kidneys from normal and HIV-Tgmale and 66 female HIV-Tg rats. Seventy-four HIV-Tg
rats were fixed in 10% formalin and embedded in paraf-rats (40 males and 34 females) were sacrificed randomly
fin. Sections (4m) were stained either with hematoxylinat different time points during the first 6 months of life,
and eosin, periodic acid-Schiff reagent (PAS), and Mas-and before they showed clinical symptoms (8 to 12 rats
son trichrome stain, following standard techniques. Forat each time point). The remaining 91 HIV-Tg rats (58
electron microscopy, tissue was fixed in 2% gluteralde-males and 32 females) were sacrificed whenever they
hyde, 2% paraformaldehyde in 0.1 mol/L cacodylateshowed clinical signs of wasting, neurologic symptoms,
buffer (pH 7.2). Samples were postfixed in 1% OsO4 andpallor, or were found moribund in their cages. Control
infiltrated with propylene oxide resin. Thin sections werenontransgenic siblings of similar age and gender were
stained with uranyl acetate and lead acetate prior tosacrificed at identical time points (3 to 10 rats at each
time point). photography.
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HIV gene expression (5-TGT GTA AAA TTA ACC CCA CTC TG-3) and
env antisense (5-ACA ACT TGT CAA CTT ATA GCTNorthern analysis. Kidneys from HIV-Tg rats of 7, 14,
GGT-3). A 500 bp fragment of the glyceraldehyde30, and 60 days of age, respectively (five male rats in
3-phosphate dehydrogenase (GAPDH) gene was ampli-each group), were snap-frozen in liquid nitrogen and
fied as an internal control using specific mouse GAPDHtotal RNA was isolated by using Trizol (Life Technolo-
primers. The PCR was performed at an annealing tem-gies, Gaithersburg, MD, USA). Total RNA (10 mg) was
perature of 58C for 30 cycles for HIV-1 env and 25 cycleselectrophoresed through 1% agarose/2.2. mol/L formal-
for GAPDH. The products were separated on 1.2% aga-dehyde gels in 1  3-[N-morpholine] propane sulfonic
rose gels and stained with ethidium bromide. In eachacid (MOPS) and transferred to Nytran membranes
experiment, distilled water was used as a negative control(Schleicher and Schuell, Keane, NH, USA). RNA was
for contamination. For quantification, the amplified cDNAultraviolet cross-linked. Radioactive probes were pre-
bands were measured by densitometry image scanningpared by the random prime method (Boehringer Mann-
as described before [24], and the product yield was ex-heim, Indianapolis, IN, USA). To detect all species of
pressed as a ratio to GAPDH.the HIV transgene RNA, we used an HIV-1 nef cDNA
probe obtained from the AIDS Repository and Refer-
Immunohistochemistry studies
ence Reagent Program, Division of AIDS, NIAIDs, NIH
Frozen sections. Kidney tissues were snap-frozen in(pGM92, contributed by Dr. John Rossi), which overlaps
22-oxacalcitriol (OCT) (Miles, Elkhart, IN, USA) usingthe viral long terminal repeats (LTR). Blots were nor-
dry ice–chilled isopentane. Sections (5  thick) weremalized by probing for the small ribosomal protein S14
brought to room temperature, fixed in cold acetone, and(American Type Culture Collection, plasmid #59247).
blocked with 5% normal goat serum, followed by incuba-Blots were washed under stringent conditions at 55C in
tion with the respective primary immunoglobuline (Ig)1 mol/L sodium phosphate, pH 7.4, 0.5 ethylenediamine-
G, A, or M (Zymed, South San Francisco, CA, USA) andtetraacetic acid (EDTA), and 10% sodium dodecyl sulfate
C3 (Biodesign Int., Kennebunk, ME, USA) antibodies,(SDS) buffer and autoradiographed at 70C. Membrane
respectively. After washing with PBS, fluorescein iso-quantification was performed using a PhosphorImager
thiocyanate (FITC)-labeled goat antirabbit antibody was(Molecular Dynamics, Sunnyvale, CA, USA), and the
applied. After further PBS washes, the slides were exam-results expressed as a ratio of HIV transgene/S14 gene
ined using a microscope equipped with epifluorescentexpression.
optics (Leica, Deerfield, IL, USA).In situ hybridization. In situ hybridization (ISH) stud-
Paraffin embedded sections. Paraffin sections were cuties were performed as previously described [22], using
at 5 m, deparaffinized, and rehydrated. Endogenousdigoxinenin-uridine triphosphate (UTP)–labeled RNA
peroxidase activity was blocked by treating with 3%probe from Lofstrands Labs (Gaithersburg, MD, USA).
H2O2 in 100% methanol for 10 minutes. ImmunostainingWe also used HIV-1 probes derived from the RNA ex-
was performed with a commercial streptavidin-biotin-pression plasmids pGM92 and pGM93, which were ob-
peroxidase complex HistostainTM SP kit (Zymed) ac-tained through the NIH AIDS Research and Reference
cording to the manufacturer‘s instructions as previouslyReagent Program, Division of AIDS, NIAID, NIH (con-
described [23, 24]. In order to identify rat mononucleartributed by Dr. John Rossi). These plasmids contain in
cells, we used ED-1, a monoclonal IgG1 antibody againstopposite orientation a 1.1 kb fragment from the 3 end
rat macrophages (Harlan, Bioproducts, Indianapolis, IN,of the HIV-1 coding region that is common to all HIV-1
USA). The HIV-1 protein, gp120, was detected withmRNA. The negative controls included (1) hybridization
a gp120 antibody (ABL, Inc., Kensington, MD, USA).with the sense probe, (2) RNase A (100 mg/mL in 10
Double staining of ED-1 and the HIV-1 gp120 was donemmol/L Tris HCl, pH 8.0,1 mmol/L EDTA) pretreat-
with the Histostain-DSTM double staining kit (Zymed).ment before hybridization, and (3) omission of either the
Vimentin expression was detected using a vimentin anti-antisense RNA probe or the antidigoxigenin antibody.
body from DAKO (Carpinteria, CA, USA). Cell prolifera-Reverse transcription polymerase chain reaction. Total
tion was evaluated by using a biotinylated antiprolifera-RNA was extracted from normal and diseased kidneys
tive cell nuclear antigen (PCNA) monoclonal antibodyusing Trizol (Gibco, BRL, Grand Island, NY, USA).
(clone PC10). In selected sections, these experiments wereReverse transcription (RT) of 2 g of total RNA was
confirmed with a rabbit antihuman Ki67 antibody fromperformed using the Reverse Transcription Kit from Pro-
DAKO. Basic fibroblast growth factor (bFGF) was iden-mega (Madison, WI, USA) as previously described [24].
tified using affinity purified IgG fractions (2.5 g/mL) fromThe resulting first-strand cDNA was used as template
a rabbit polyclonal antibody directed against uniquefor subsequent polymerase chain reaction (PCR) using
peptide sequence of bFGF (provided by Dr. A. Baird,the Advantage PCR Kit from Clontech (Palo Alto,
PRIZM Pharmaceuticals, San Diego CA, USA) [25], andCA, USA). The primers used to amplify the HIV-1 trans-
gene were the following env specific primers: env-sense a murine monoclonal antibody against rh-bFGF DE6
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(provided by Dr. T. Reilly, Dupont-Merck, Wilmington, SEM; N  10 rats per group; P  0.05 when compared
to normal rats, respectively). Serum levels of cholesterolDE, USA) [26]. Controls included replacing the primary
antibody with equivalent concentrations of nonimmune and triglycerides were further increased in HIV-Tg rats
of similar age with chronic renal failure (data not shown).IgG and omitting the first antibodies. Analysis of the
immunohistochemistry data.was done using a computer- These rats also showed lower hematocrit values (35% 
4%) when compared to HIV-Tg rats without renal dis-assisted image analysis software (Optimas version 6.2;
Media Cybernetics, Silver Spring, MD, USA) and digital- ease (46% 3%) or their corresponding normal control
littermates (47%  2%).ized images. All sections were stained under identical
conditions and compared independently by two investi- To evaluate the course of the renal disease, we mea-
sured the urinary protein excretion in control and HIV-Tggators. The percentage of renal glomerular/medullar in-
terstitial areas that stained positive for each antibody in rats followed longitudinally from birth. At 7 days of age,
significant proteinuria (100 mg/dL) was detected in10 microscopic fields at 50 was measured. A semiquan-
titative scoring system (0 to 4) was used: 0  0% to 5%, approximately 3% of the HIV-Tg rats. By 14 days of
age, 10% of the HIV-Tg rats showed significant protein-1  6% to 15%, 2  16% to 25%, 3  26% to 50%,
and 4  51% to 100%. The number of PCNA-positive uria, with protein/creatinine ratios of 13  2 (mean 
SEM). Among 165 HIV-Tg rats, 32% developed ESRDcells and macrophages (ED-1–positive cells/mm2) in re-
nal glomeruli and medulla was also counted. before or at 100 days of life, and these animals showed
urine protein/creatinine ratios of 65 5 (mean SEM).
Statistical analysis In contrast, control rats of similar age showed protein
values 30 mg/dL by urine dipstick or mean protein/Results are expressed as the mean value  SEM. Dif-
ferences between two groups were compared by Student creatinine ratios of 4  1.6. Approximately 60% of the
total number of HIV-Tg rats developed ESRD beforet test. When more than two means were compared, differ-
ences were measured by one-way analysis of variance or at 1 year of age, while none of the normal littermates
developed ESRD. These data however, may not accu-(ANOVA) followed by multiple comparisons using the
Student-Neuman-Keul’s test. The nonparametric Kruskal- rately reflect the incidence of ESRD at 100 and 360 days,
respectively, since many rats with and without symptomsWallis test was used whenever the distribution of the
data did not follow a Gaussian distribution. P values less were sacrificed before they reached these time points.
than 0.05 were considered significant.
Correlation between clinical and histologic findings
The renal disease was detected earlier, and it was more
RESULTS
severe in male HIV-Tg rats. Among the 74 HIV-Tg rats
HIV-Tg rat model that were sacrificed randomly during the first 6 months
of life (40 males and 34 females), uremia was detectedBy Southern blots analysis in DNA extracted from
HIV-Tg rats (line 1), we confirmed our previous findings most frequently in male rats (3:1 ratio). In addition,
more HIV-Tg male rats developed ESRD within the first[22], by detecting a dominant 7.4 kb HIV-1 band corre-
sponding to 20 to 25 transgene copy numbers, as esti- month of life (4 males vs. 1 female). Of interest, young
HIV-Tg rats showed a faster rate of progression of themated from the relative intensity of hybridization to
Southern blots of transgene DNA compared to serial renal disease when compared to older rats. Approxi-
mately 70% of the HIV-Tg rats, in which proteinuriadilutions of known amounts of transgene DNA frag-
ments (data not shown). (100 mg/dL) was detected during the first 20 days of
life, developed ESRD within 25 days. In contrast, only
Clinical and biochemical outcome 30% of the HIV-Tg rats, in which similar levels of pro-
teinuria were detected at approximately 45 days of age,Whereas all control nontransgenic littermates had nor-
mal life spans and lacked clinical, biochemical, and histo- developed ESRD within a similar period of time (N 
10 rats in each group, P  0.05).pathologic evidence of ESRD throughout the course of
the study, all HIV-Tg rats developed significant protein- Approximately 17% of the HIV-Tg rats without clini-
cal symptoms, and sacrificed randomly during the first 8uria before reaching 18 months of age, and approxi-
mately 80% developed ESRD by this time. In HIV-Tg weeks of life, showed histologic evidence of HIVAN. In
contrast, 62% of the HIV-Tg rats sacrificed during therats with normal kidneys (40 days of age), mean serum
albumin was 4.4  0.2 g/dL, serum cholesterol was 59  first 8 weeks of life due to the presence of clinical symp-
toms, showed histologic evidence of HIVAN. Overall,4 mg/dL, and serum trigylcerides was 147  12 mg/dL.
In contrast, in HIV-Tg rats of similar age with heavy 84% of the HIV-Tg rats sacrificed during first 6 months
of age due to the presence of clinical symptoms showedproteinuria but normal renal function, serum albumin
was 3.5 0.1 g/dL, serum cholesterol was 104 7 mg/dL, histologic evidence of HIVAN (100% males and 70%
females). In HIV-Tg rats that developed clinical symp-and serum triglycerides were 327  12 mg/dL (mean 
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toms after 6 months of age (37 males and 15 females), perivascular inflammatory cells localized predominately
to the adventitia and interstitium surrounding the renal98% of all males and 50% of all females showed histo-
logic evidence of HIVAN. Only 10% of all HIV-Tg rats vessels (Fig. 1A, panel D). On gross inspection, the kid-
neys from HIV-Tg rats with chronic renal failure werefollowed during the study period did not develop histo-
logic evidence of HIVAN (95% of these rats were fe- diffusely pale and enlarged (35%  8% increased in
weight when compared to kidneys from the littermatemale). None of the control animals sacrificed during the
study period developed chronic renal failure or histologic control rats). As shown in Figure 1B (panels A and B),
the capsular surface of HIV-Tg kidneys with late renalevidence of HIVAN.
disease was pitted, similar to that seen in humans with
Blood pressure HIVAN. Some glomeruli showed evidence of capillary
collapse, and others showed either segmental or globalHealthy controls, HIV-Tg rats without renal disease,
and HIV-Tg male rats with proteinuria but without sclerosis Figure 1B (panels C and D). By PAS and Mas-
son trichrome staining, renal sections from HIV-Tg ratschronic renal failure (40 days old), showed mean nor-
mal systolic blood pressure levels of 103  5 mm Hg, with late-stage renal disease showed an accumulation of
extracellular matrix proteins in sclerotic glomeruli, renal101  3 mm Hg, and 106  4 mmHg (mean  SEM),
respectively (N  10 rats in each group; P  005). In interstitium, and around dilated tubules (Figs. 1B and
2). Glomerular parietal and visceral epithelial cells ap-contrast, HIV-Tg rats of similar age and gender (N  5)
but with chronic renal failure, showed higher systolic peared reactive and enlarged. These kidneys also showed
microcystic tubular dilatation with epithelial cell atro-blood pressure levels, 143  8 mm Hg (P  0.05). Older
HIV-Tg rats (6 months of age) with proteinuria but phy, attenuation and degeneration of the tubular epithe-
lium. Some tubules were filled with PAS-positive casts.without chronic renal failure also showed normal systolic
blood pressure levels of 105  6 mm Hg (N  8). A There was diffuse infiltration of mononuclear cells adja-
cent to dilated tubules and in glomeruli undergoing dif-detailed histologic examination of renal sections from
10 HIV-Tg rats with proteinuria without chronic renal ferent stages of the renal disease. These mononuclear
cells stained positive with an antibody against the HIV-1failure and normal blood pressure confirmed the pres-
ence of focal segmental glomerulosclerosis in all rats, protein gp120 and ED-1 (Fig. 3C).
and renal arteriopathy in three rats.
Electron microscopy
Captopril treatment By transmission electron microscopy, the foot pro-
cesses of the visceral epithelium in normal rats wereHIV-Tg rats with proteinuria but without renal failure
treated with captopril for 7 days (N 4), showed a signifi- clearly seen along the glomerular basement membrane
(Fig. 4A). In contrast, effacement and fusion of footcant reduction in systolic blood pressure levels (102 
3 mm Hg vs. 80  4 mm Hg) (mean  SEM, before processes were found in diseased HIV-Tg rat kidneys
(Fig. 4B). Visceral epithelial cells showed cytoplasmicand after treatment respectively, P  0.05). Captopril
treatment did not significantly affect the systolic blood vacuoles and protein reabsorption droplets. Capillary lu-
mina were narrowed or obliterated, the basement mem-pressure in normal healthy control rats (data not shown).
In HIV-Tg rats, captopril treatment decreased the urine branes were thickened, and endothelial cells were swollen
but without tubuloreticular inclusions. We did not findprotein/creatinine ratio (19  4 vs. 6.7  2) (mean 
SEM, before and after treatment, respectively, P 0.05). subcellular ultrastructural particles suggestive of the
presence of immune deposits. Evidence of a focal degen-In contrast, HIV-Tg rats with proteinuria but without
renal failure, treated with vehicle for 7 days (N  4), erative process was found in renal tubules of HIV-Tg
rats with heavy proteinuria and tubular casts (Fig. 4D).showed no significant changes in systolic blood pressure
levels (100  4 mm Hg vs. 106  6 mm Hg) and urinary Renal tubular epithelial cells revealed focal atrophy, loss
of microvilli, and decreased number of mitochondria.protein excretion (protein/creatinine, 8.6 2 vs. 13 4)
(mean SEM) before and after treatment, respectively. HIV-Tg rats with late-stage renal disease showed severe
renal tubulointerstitial injury with generalized tubular
Renal pathology dilatation and atrophy.
On renal histology, glomerular enlargement with mes-
HIV-1 RNAangial hyperplasia (Fig. 1A, panel B), mild tubular dilata-
tion, and infiltration of mononuclear cells were common To determine the expression of HIV-1 mRNA through-
out the process of rapid kidney growth, we extractedlesions seen during the early stages of the renal disease
in young rats. Approximately 15% of HIV-Tg rats devel- kidney RNA from HIV-Tg rats of 7, 14, 21, and 60 days
of age, respectively (N  5 rats per group). By Northernoped a renal arteriopathy characterized by endothelial
injury, medial thickening due to hypertrophy/hyperpla- blot analysis, the single-spliced 4 kb proviral mRNA was
the most abundant band detected in young rats (Fig.sia of vascular smooth muscle cells, and the presence of
Fig. 1A. A Renal disease in human immunodeficiency virus transgenic Fig. 2. Masson trichrome staining in renal sections from human immu-
nodeficiency virus transgenic (HIV-Tg) rats with and without renal(HIV-Tg) rats. (A and C) A representative hematoxylin and eosin staining
in glomeruli and renal vessels of HIV-Tg rats without renal disease. disease. Representative sections of the renal cortex (A ) and medulla
(C ) of HIV-Tg rats without renal disease, and the renal cortex (B )(B) A representative renal section of an HIV-Tg rat with mesangial
hyperplasia, undergoing the early stages of the renal disease. The arrow and medulla (D ) of HIV-Tg rats with late renal disease. Note the
accumulation of extracellular matrix proteins (blue color) in renal glo-points to a focal adhesion of a distal glomerular tuft to Bowman’s capsule.
(D) A representative hematoxylin and eosin staining in an HIV-Tg rat meruli and tubulointerstitium in HIV-Tg rats with renal disease (B to
D) (original magnification 400).with renal arteriopathy (original magnification 350).
Fig. 3. Immunhistochemistry staining for mononuclear cells (ED-1–
positive cells) and gp120 in human immunodeficiency virus transgenic
(HIV-Tg) rats with human immunodeficiency virus-associated nephrop-
athy (HIVAN). (A ) Few ED-1–positive cells in the renal cortex of an
HIV-Tg rat without renal disease (original magnification 250). (B )
A diseased glomerulus of an HIV-Tg rat with late renal disease (originalFig. 1B. Late renal disease in human immunodeficiency virus trans-
genic (HIV-Tg) rats. (A and B ) Macroscopic pictures of the kidneys magnification350). (C ) Recruitment of ED-1–positive cells (red stain)
in the renal medulla of an HIV-Tg rat with late renal disease (originalof HIV-Tg rat with late renal disease. Note the pitted external and
internal renal surfaces (original magnification 4). A representative magnification250). (D ) A representative colocalization immunohisto-
chemistry staining of ED-1 (red stain) and gp120 (dark stain) in the renalperiodic acid-Schiff (PAS) staining of the renal cortex (C) and medulla
(D) in sections of HIV-Tg rats with late renal disease. A representative medulla of an HIV-Tg rat with late renal disease (original magnification
500). (E ) shows gp120–positive cells (dark stain) in the renal medullaPAS staining of the renal cortex (E) and medulla (F) in sections of
HIV-Tg rats without renal disease. Increased PAS	 staining is detected of an HIV-Tg rat with renal disease (original magnification 500). (F )
A renal section from the same rat incubated with a non immune controlin sclerotic glomeruli (C) and dilated tubules (D) of HIV-Tg rats with
renal disease (original magnification 100). antibody (original magnification 500).
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Fig. 4. Transmission electron micrographs of renal sections of normal
and diseased human immunodeficiency virus transgenic (HIV-Tg) rats.
(A ) A normal glomerular structure of a normal rat kidney. (B ) A
glomerulus of an HIV-Tg rat with late renal disease. Note the efface-
ment of podocytes, visceral epithelial cell cytoplasmic vacuoles and
protein reabsoption droplets, thickened basement membranes, and cap-
illary collapse. (C ) A normal renal tubular structure of a control rat,
characterized by the presence of microvilli, mitochondria, lysosomes,
and basal infolding of cell membranes. (D) A representative renal tubule
of an HIV-Tg rat with renal disease. Note the absence of microvilli,
scarcity of cellular organella, degeneration of epithelial cells, and protein-
aceous material in the luminal fluid (original magnification 7000).
5A). Older rats showed higher levels of the 7.4 kb and
2 kb proviral mRNA (Fig. 5A). By RT-PCR studies with
RNA extracted from rats of similar age and gender, with
and without renal disease (N  6 rats in each group),
we found a mean reduction in HIV-1 mRNA expression
of approximately 85% in diseased HIV-Tg kidneys. Fig-
ure 5B shows the results of one representative experi-
Fig. 5. Analyses of total kidney RNA extracted from humun immuno-ment done in five HIV-Tg rats. By ISH, HIV-1 mRNA deficiency virus transgenic (HIV-Tg) rats. (A ) Northern blot analysis
was detected in renal tubular and glomerular epithelial of total kidney RNA extracted from HIV-Tg rats without renal disease.
RNA samples were hybridized with a nef cDNA probe that hybridizescells, but no in other renal cell types (Fig. 6). Interest-
with all proviral mRNAs (upper panel) and with the S14 probe (loweringly, HIV-1 mRNA expression was decreased in glo- panel) to demonstrate equal loading of RNA in each lane. Lane 1, RNA
meruli with severe focal segmental glomerulsclerosis sample from HIV-Tg rats sacrificed at 7 days of age; lane 2, RNA sample
from HIV-Tg rats sacrificed at 14 days of age; lane 3, RNA sample from(Fig. 6A), and was not diminished in dilated/microcystic
HIV-Tg rats sacrificed at 21 days of age; and lane 4, RNA sample fromrenal tubules. Finally, by ISH studies, we failed to detect HIV-Tg rats sacrificed at 60 days of age. In each group, total kidney RNA
HIV-1 mRNA expression in renal vessels. extracted from five different HIV-Tg male rats was pooled. Three HIV
RNA size bands of approximately 7.4 kb, 4 kb, and 2 kb were detected.
(B ) Reverse transcription-polymerase chain reaction (RT-PCR) analy-Immunohistology
sis of total kidney RNA extracted from HIV-Tg rats. Amplified products
Frozen renal sections from HIV-Tg rats with late renal were resolved on 1% agarose gels and visualized with ethidium bromide
staining. Primers were specific for a 201 bp fragment of HIV-1 env (upperdisease revealed deposition of coarse granular aggre-
panel) and a 500 bp fragment of the mouse glyceraldehyde-3-phosphategates of IgM, and occasionally IgG only in severely scle- dehydrogenase (GAPDH) gene (lower panel). Molecular weight marker
rotic glomeruli, but lesser amounts of IgA and C3 in the 
X174RF/Hae III; lane 1, distilled water; lanes 2, 3, and 5, total kidney
RNA extracted from HIV-Tg rats with late renal disease; lanes 4 andsame structures (data not shown). Kidneys from normal
6, total kidney RNA extracted from HIV-Tg rats without renal disease.littermates or from HIV-Tg rats without renal disease or A linear relationship between input RNA and HIV-RNA amplification
during the early stages of it did not show evidence of was noted after 25 to 30 cycles of amplification for HIV-1 env and
GAPDH, respectively.immune deposits (data not shown). HIV-Tg rats with
renal disease showed a significant recruitment of PCNA-
positive cells both in renal glomeruli and medulla (Fig.
7). These findings were reproduced in selected renal
sections with a Ki67 antibody (data not shown). The
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Table 1. Comparison of immunohistochemistry scores between
normal and human immunodeficiency virus (HIV)-transgenic
(HIV-Tg) rats with HIV-associated nephropathy (HIVAN)
HIV-Tg rats with
Normal rats late renal disease
PAS, glomerular interstitial
staining hpf 1.20.2 3.60.16a
PAS, medullar interstitial
staining hpf 1.70.2 3.80.2a
Masson trichrome, glomerular
interstitial staining hpf 1.40.16 3.40.16a
Masson trichrome, medullar
interstitial staining hpf 1.60.3 3.70.15a
Vimentin staining in
glomerular cells hpf 3.90.1 2.70.2a
Vimentin staining in tubular
epithelial cells hpf 0.20.1 3.80.13a
bFGF staining in renal
glomeruli hpf 1.30.15 3.40.3a
bFGF staining in renal
Fig. 6. In situ hybridization (ISH) studies for human immunodeficiency medulla hpf 1.90.3 3.40.2a
virus-1 (HIV-1) in renal sections from HIV transgenic (HIV-Tg) rats PCNA-positive cells in renal
with HIV-associated nephropathy (HIVAN). (A and B) Representative glomeruli cells/mm2 2.00.3 10.01.2a
renal sections of HIV-Tg rats with late renal disease hybridized with PCNA-positive cells in renal
the HIV-1 antisense probe as described in the Methods section. HIV- medulla cells/mm2 10.01 79.02a
RNA (dark stain) was detected in renal tubular epithelial cells (original Glomerular macrophages
magnification250). (C ) A representative ISH study in a renal glomer- ED-1 positive cells/mm2 1.20.2 18.00.9a
ulus hybridized with the HIV-antisense probe. HIV-RNA (dark purple Medullary macrophages ED-1
stain) was detected predominately in podocytes and parietal epithelial positive cells/mm2 6.00.8 45.05a
cells (original magnification 800). (D ) A representative renal section
Abbreviations are: PAS, periodic acid-Schiff; hpf, high power field; bFGF,of an HIV-Tg rat with late renal disease hybridized with the HIV-sense
basic fibroblast growth factor; PCNA, proliferating cell nuclear antigen.probe (original magnification 250).
MeanSEM. The following semiquantitative scoring system was used: 0  0%
to 5% cells or interstitial area stained; 1  6% to 15%; 2  16% to 25%; 3 
26% to 50%; and 4  51% to 100%. The number of PCNA and macrophages
(ED-1-positive) cells/mm2 was counted both in renal glomeruli and medulla.
aP  0.05. N  10 male rats per group (40 days of age).proliferative changes were associated with the accumula-
tion of mononuclear cells and accumulation of bFGF in
renal glomeruli and tubulointerstitium (Fig. 8B), com-
pared to renal sections from control rats (Table 1), or To gain further insight into the pathogenesis of child-
from HIV-Tg rats of similar age without renal disease hood HIVAN, we followed the clinical and renal patho-
(Fig. 8A). Two different specific bFGF antibodies with logic outcome of the first HIV-Tg rat model, focusing
their corresponding control antibodies were used as de- on the most relevant pathogenic features of childhood
scribed in the Methods section to confirm these findings. HIVAN. These HIV-Tg rats carry as a transgene a dele-
Finally, to determine, whether renal epithelial cells were tion mutant of the infectious proviral clone pNL4-3 con-
undergoing simultaneous dedifferentiation changes, we taining the open reading frames for env, the accessory
determined the expression of vimentin. Renal sections genes nef, vif, vpr, and vpu, and the regulatory genes tat,
from HIV-Tg without renal disease, showed vimentin- and rev, under the control of the viral LTR [22]. Here,
positive staining localized to renal glomeruli and intersti- we have shown that the expression of HIV-1 genes/viral
tial cells (Fig. 8C). In contrast, sections from HIV-Tg proteins in circulating mononuclear cells and renal epi-
rats with late renal disease showed a reduced number thelial cells, as well as the accumulation of bFGF in the
of glomerular cells expressing vimentin, in combination kidney, were associated with the development of clinical
with a significant recruitment of tubular epithelial cells
and renal histologic lesions similar to those seen in child-
expressing vimentin in dilated and/or microcystic renal
hood HIVAN [9–11].tubules (Fig. 8D).
Previous studies in HIV-1 transgenic mice have pro-
vided a significant advance in our understanding of the
DISCUSSION pathogenesis of HIVAN [12–14, 17, 27]. In this study,
we have used the only HIV-Tg rat line available, andHIVAN is an important cause of ESRD among young
therefore, it could be argued that the renal disease couldAfrican Americans infected with HIV-1 [1–6]. Despite
be due to the interruption of a host gene. On the otherthe significant advances made during the last years using
hand, the lesions found in these HIV-Tg rats, resembledifferent animal models of HIVAN [12, 13, 17, 27–30],
those seen in the HIV-1 transgenic mouse line Tg26 [12–the exact pathogenic mechanisms responsible for the
development of HIVAN are not completely understood. 14, 17], which carry approximately the same copy number
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Fig. 8. Immunohistochemistry staining for basic fibroblast growth fac-Fig. 7. Immunohistochemistry staining for the proliferating nuclear an-
tor (bFGF) and vimentin in renal sections from human immunodefi-tigen (PCNA) in renal sections of human immunodeficiency virus trans-
ciency virus transgenic (HIV-Tg) rats with and without renal disease.genic (HIV-Tg) rats with and without renal disease. (A ) A representa-
(A ) A representative bFGF staining (red color) of the renal cortextive section of the renal cortex of an HIV-Tg rat without renal disease.
from and HIV-Tg rat without renal disease. Faint bFGF staining isPCNA positive cells are stained in red color. (B ) A representative
detected in glomerular and peritubular structures. (B ) A representativesection of the renal medulla of an HIV-Tg rat without renal disease.
bFGF staining of the renal cortex from an HIV-Tg rat with late stage(C ) A representative section of the renal cortex from an HIV-Tg rat
renal disease. bFGF staining is increased in renal glomeruli, tubules,with late stage renal disease. (D ) A representative section of the renal
and interstitial structures (original magnification 350). These resultsmedulla from an HIV-Tg rat with late stage renal disease (original
were reproduced with two different antibodies as described in the Meth-magnification 250).
ods section. (C ) A representative vimentin staining (red color) of the
renal cortex from an HIV-Tg rat without renal disease. (D ) A represen-
tative vimentin staining of the renal cortex from an HIV-Tg rat with
late stage renal disease (original magnification350). HIV-Tg rats withof an identical HIV-1 transgene. In both transgenic mod-
late-stage renal disease show a reduced number of glomerular cellsels, the viral LTR regulates the expression of the trans-
expressing vimentin (C) and (D), and a significant recruitment of vimen-
gene, and epithelial cells are the intrinsic renal cells ex- tin-positive cells in dilated and/or microcystic tubules. Sections stained
with irrelevant antibody controls for bFGF and vimentin did not revealpressing HIV-1 genes. Three sizes of viral transcripts are
positive staining (data not shown).detected in the kidney of HIV-Tg26 mice [12–14] and
rats. These findings suggest that rev, a viral protein that
regulates splicing can function both in rats and mice. In
addition, the HIV-1 envelope protein gp120 is present lymphoid cells. Overall, the presence of HIVAN in two
the circulation and produced by mononuclear cells of
different transgenic rodent models that carry the same
HIV-Tg rats [22], while gp120 is not detected in the circula-
HIV-1 transgene and the expression of HIV-1 genes/tion or mononuclear cells in HIV-Tg26 mice [12, 13]. Ear- proteins in rat mononuclear cells strongly suggest thatlier reports on cultured human endothelial cells, have
the renal disease in HIV-Tg rats is induced by HIV-1.shown that gp120 can induce cytotoxic effects through
Despite the similarities between both HIV-Tg models,a CXC chemokine receptor 4 (CXCR-4–mediated mech-
we have identified some interesting clinical and histo-anism independently of the CD4 receptor [31, 32]. In
logic features in HIV-Tg rats that are clinically relevantaddition, some HIV-1 strains can interact with the rat
for studying the pathogenesis of childhood HIVAN.homolog of CXCR-4 [33], and the envelop protein in-
First, HIV-Tg rats develop mesangial hyperplasia duringduces in vivo neurotoxicity in mice [34] and rats through
the early stages of the renal disease (Fig. 1A) and thisa similar mechanism [35]. Moreover, immunization of
is a typical lesion seen in children with HIVAN [9–11].HIV-Tg26 mice with recombinant HIV-1 gp160 prolonged
We have failed to detect HIV-1 mRNA in mesangialthe survival and improved the outcome of their renal
cells of HIV-Tg rats and HIV-infected children with re-disease [36]. Taken together, these observations suggest
nal disease [38]. Thus, this model could be used to studythat gp120 may play a role in the pathogenesis of the
alternative mechanisms by HIV-1 induces mesangial hy-renal disease in HIV-Tg rats. At the present time, how-
perplasia in children. Second, the absence of edema andever, the mechanisms responsible for the activation of
hypertension during the early stages of HIVAN, and thethe HIV-1 transgene, in rat mononuclear cells are not
observation that captopril treatment induced hypoten-clearly understood. The HIV-LTR is transactivated by
sion in previously normotensive HIV-Tg rats with pro-the viral Tat protein, which requires cellular cyclin T as
teinuria, suggest that their intravascular volume statusa cofactor [37]. Thus, it is possible that the rat cyclin T
may have a more functional interaction with Tat in rat may be slightly contracted. In a similar manner, HIV-
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infected children with proteinuria frequently develop in- The renal histologic lesions in HIV-Tg rats are also
strikingly similar to those found in HIV-infected patientstravascular volume contraction whenever their fluid in-
take is limited or undergo fluid electrolyte losses due to [1–3, 9–11]. Focal segmental or global sclerosis, collaps-
ing glomerulopathy, microcysts, and tubulointerstitial le-intercurrent illness. Children have a higher rate of basal
heat production per kilogram of body weight than adults, sions leading to renal enlargement are typically seen in
both children and adults with HIVAN. In HIV-Tg rats,and their metabolic, fluids, and electrolyte needs increase
considerably during an acute illness and periods of catch- proteinuria was detected as early as the first week of
life, and always preceded the development of the renalup growth. Therefore, these HIV-Tg rats could be used
to study the pathogenesis of fluid electrolytes and growth- histologic lesions. The appearance of proteinuria as the
initial clinical sign of HIVAN may be at least partiallyrelated problems of HIV-infected children. Third, HIV-Tg
rats that developed proteinuria during the first 2 to 3 explained by the induction of podocyte injury by HIV-1
genes/viral proteins [7, 39, 40]. On the other hand, theweeks of life showed a rapid progression to ESRD, sug-
gesting that the developing rat kidney is very sensitive renal arteriopathy in HIV-Tg rats was not associated
with the expression of HIV-1 mRNA in vascular endo-to the adverse effects of HIV genes/viral products. In
contrast, older HIV-Tg rats underwent longer periods of thelial or smooth muscle cells and could be detected
even in rats without hypertension. Tinkle et al [41], usingproteinuria before they developed ESRD. These findings
resemble the clinical situation seen in HIV-infected chil- a different HIV-Tg mouse model, described a vasculopa-
thy induced by the expression of HIV-1 mRNA in vascu-dren, in whom both short and long periods of heavy
proteinuria may precede the development of ESRD lar smooth muscle cells and the recruitment of inflam-
matory cells in the adventitia. They suggested that FGFs[9–11]. Finally, the accumulation of bFGF in the renal
cortex and medulla of HIV-Tg rats with renal disease released by smooth muscle and inflammatory cells may
contribute to the pathogenesis of these lesions. In sup-also mimics the situation of HIV-infected children with
renal disease [24, 38]. port of this notion, we have found an accumulation of
inflammatory cells and bFGF in diseased HIV-Tg ratOther findings in HIV-Tg rats may be relevant to study
the pathogenesis of HIVAN in both children and adults. kidneys. However, more studies will be needed to eluci-
date the basic mechanism by which HIV-1 induces renalFor example, one issue explored for the first time in
HIV-Tg rats was to determine whether changes in blood arteriopathy. Taken together, these findings suggest that
HIV-1 may induce the development of renal lesions inpressure contributed to the pathogenesis of the renal
disease and vascular arteriopathy. To the best of our HIV-Tg rats by injuring intrinsic renal cells and releasing
viral proteins and cytokines.knowledge, this issue has not been studied in other HIV-Tg
mouse models. HIV-Tg rats with heavy proteinuria but A typical finding in HIVAN is the presence of renal
enlargement and formation of renal microcysts. We havenormal renal function showed normal systolic blood
pressure levels, suggesting that hypertension per se does shown that an excessive proliferation of renal tubular
epithelial cells is at least partially responsible for thesenot play a major role in the initial stages of HIVAN
and/or development of the renal arteriopathy. These changes [17]. However, it is not clear whether HIV-1
gene products, per se, cytokines, or a combination of bothfindings validate the HIV-Tg rat animal model system,
since hypertension is not a major factor modulating the factors, are responsible for these proliferative changes.
Here, we have detected an overall reduction in the steady-outcome/progression of the renal disease during the early
stages in patients with HIVAN. Moreover, HIV-Tg rats, state levels of HIV-1 mRNA in diseased HIV-Tg rat
kidneys. These findings may be due to the generalizedunlike HIV-Tg26 mice, do not develop edema or ascitis
throughout the progression of the renal disease. In a renal tubular injury, since epithelial cells are the predom-
inant intrinsic renal cells expressing HIV-1 mRNA.similar manner, many HIV-infected children and adults
do not show signs of edema despite the presence of heavy However, by ISH studies, we found a robust expression
of HIV-1 mRNA in epithelial cells surrounding the renalproteinuria. Taken together, these observations may ex-
plain the lack of hypertension typically seen in HIV- microcysts. Thus, it could be argued that HIV-1 genes
might be directly responsible for the proliferation ofinfected patients with heavy proteinuria and normal re-
nal function. In contrast, during the late stages of the renal epithelial cells [40]. Alternatively, cytokines re-
leased by injured renal cells may also induce the prolifer-renal disease, HIV-Tg rats developed systolic hyperten-
sion, which is probably related to the expansion of the ation and up-regulate the expression of HIV-1 mRNA
in mononuclear cells [42] or regeneration of epithelialextracellular fluid volume associated with ESRD. Over-
all, these data suggest that captopril treatment could at cells. In support of this notion, the changes in vimentin
expression in renal glomerular and tubular epithelialleast potentially improve the clinical outcome of HIVAN
by reducing the proteinuria and improving the control cells suggest these cells are undergoing active regenera-
tive changes. In addition, regenerating tubular epithelialof blood pressure during the early and late stages of
HIVAN, respectively. cells isolated from the urine of children with HIVAN
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syndrome-associated renal disease in children. J Pediatr 113:39–44,express high levels of bFGF and are sensitive to the growth
1988
promoting effects of bFGF [38]. Moreover, we have found 10. Strauss J, Abitbol C, Zilleruelo G, et al: Renal disease in chil-
dren with acquired immunodeficiency syndrome. N Engl J Meda significant accumulation of bFGF in renal glomeruli
321:625–630, 1989and tubulointerstitium of children with HIVAN [24], and
11. Ray PE, Rakusan T, Loechelt BJ, et al: Human immunodeficiency
HIV-Tg rats show similar findings. Overall, the accumu- virus (HIV)-associated nephropathy in children from the Washing-
ton, D.C. area: 12 years’ experience. Semin Nephrol 18:396–405,lation of bFGF in glomeruli and tubulointerstitium of
1998HIV-Tg rats and children with HIVAN may contribute
12. Dickie P, Felser J, Eckhaus M, et al: HIV-associated nephropathy
to the pathogenesis of the renal disease by changing the in transgenic mice expressing HIV-1 genes. Virology 185:109–119,
1991permeability of renal capillaries [43, 44], affecting the
13. Kopp JB, Klotman ME, Adler SH, et al: Progressive glomerulo-growth of podocytes [45, 46], and inducing the prolifera- sclerosis and enhanced renal accumulation of basement membrane
tion of renal epithelial [17, 24], mesangial [38], and vascu- components in mice transgenic for human immunodeficiency virus
type 1 genes. Proc Natl Acad Sci USA 89:1577–1581, 1992lar smooth muscle cells [26, 41].
14. Viani RM, Danker WM, Muelenaer PA, Spector SA: Resolution
of HIV-associated nephrotic syndrome with highly active antiret-
roviral therapy delivered by gastrostomy tube. Pediatrics 104:1394–
CONCLUSION 1396, 1999
15. Wali RK, Drachenberg CI, Papadimitriou JC, et al: HIV-1 associ-When interpreted in the context of previous studies,
ated nephropathy and response to highly-active antiretroviral ther-
our data support the notion that HIV-1 plays a direct apy. Lancet 352:783–784, 1998
16. Winston JA, Bruggeman LA, Ross MD, et al: Nephropathy androle in the pathogenesis of HIVAN, at least partially by
establishement of a renal reservoir of HIV type 1 during primaryaffecting the growth and differentiation of renal glomer-
infections. N Engl J Med 344:1979–1984, 2001
ular and tubular epithelial cells and by inducing the re- 17. Ray PE, Bruggeman LA, Weeks BS, et al: bFGF and its low affinity
receptors in the pathogenesis of HIV-associated nephropathy incruitment of mononuclear cells and the accumulation of
transgenic mice. Kidney Int 46:759–772, 1994bFGF in the kidney. Hopefully, these rats will provide 18. Ray PE, Liu XH, Henry D, et al: Infection of human primary
a valuable model system to study the pathogenesis of renal epithelial cells with HIV-1 from children with HIV-associated
nephropathy. Kidney Int 53:1217–1229, 1998HIVAN and to test novel therapies to prevent the pro-
19. Conaldi PG, Biancone L, Botelli A, et al: HIV-1 kills renalgression of this disease. tubular epithelial cells in vitro by triggering an apoptotic pathway
involving caspase activation and Fas upregulation. J Clin Invest
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